Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
ViewRay, Inc. (VRAY) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/27/2023 8-K Quarterly results
Docs: "ViewRay Announces Fourth Quarter and Full Year 2022 Results",
"FY 2022 FY 2022 FY 2021"
08/02/2022 8-K Investor presentation, Quarterly results
Docs: "ViewRay Announces Second Quarter 2022 Results",
"Q2 2022 Q2 2022 Q2 2021",
"ViewRay and Katie Couric Media Partner to Raise Awareness about MRIdian® MRI-Guided Radiation Therapy Multiyear campaign will highlight clinical evidence and patient impact of MRIdian® for cancer treatment"
05/05/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
11/04/2021 8-K Investor presentation, Quarterly results
Docs: "ViewRay Reports Third Quarter 2021 Results",
"Our Mission: Treat and"
08/05/2021 8-K Investor presentation, Quarterly results
Docs: "ViewRay Reports Second Quarter 2021 Results",
"5 1 2 3 5 5"
05/06/2021 8-K Quarterly results
03/04/2021 8-K Quarterly results
11/05/2020 8-K Investor presentation, Quarterly results
Docs: "Second Amendment to Loan and Security Agreement, by and among ViewRay, Inc., ViewRay Technologies, Inc. and Silicon Valley Bank",
"ViewRay Reports Third Quarter 2020 Results",
"WE ARE DOING IT TODAY:"
07/30/2020 8-K Quarterly results
04/30/2020 8-K Quarterly results
Docs: "Offer Letter to Zachary Stassen",
"ViewRay Reports First Quarter 2020 Results",
"ViewRay Names Zach Stassen as Chief Financial Officer"
03/12/2020 8-K Quarterly results
11/12/2019 8-K Quarterly results
08/08/2019 8-K Quarterly results
05/02/2019 8-K Quarterly results
Docs: "ViewRay Reports First Quarter 2019 Results"
03/14/2019 8-K Quarterly results
Docs: "ViewRay Reports Fourth Quarter and Full Year 2018 Results"
08/03/2018 8-K Quarterly results
Docs: "ViewRay Reports Second Quarter 2018 Financial Results"
05/10/2018 8-K Quarterly results
Docs: "Certificate of Elimination of the Series A Convertible Preferred Stock",
"Amended and Restated Bylaws of ViewRay, Inc",
"ViewRay Reports First Quarter 2018 Financial Results Reiterates 2018 Financial Guidance"
03/12/2018 8-K Quarterly results
Docs: "ViewRay Reports Fourth Quarter and Full Year 2017 Financial Results Achieved Record Levels of Revenue, Gross Orders and Backlog for Fourth Quarter and Full Year Introduces 2018 Revenue Guidance of $80-$90 Million"
11/13/2017 8-K Quarterly results
Docs: "ViewRay Reports Third Quarter 2017 Financial Results Strong Order Momentum in Q3, continuing in Q4"
08/07/2017 8-K Quarterly results
Docs: "ViewRay Reports Second Quarter 2017 Financial Results On Track to Achieve 2017 Financial Guidance"
05/15/2017 8-K Form 8-K - Current report
03/16/2017 8-K Form 8-K - Current report
11/14/2016 8-K Quarterly results
Docs: "Received 4 new orders for MRIdian Systems, totaling $24.5 million, up from 3 orders in Q2 and 2 orders in Q1 • Total backlog of $125.2 million, representing 22 signed sales contracts, as of September 30, 2016 • Completed $13.8 million private placement • Expanded Asia-Pacific market opportunity with MRIdian System regulatory approval in Japan and China • Clinical experience of MRIdian System’s unique abilities to treat cancer patients highlighted at ASTRO"
08/15/2016 8-K Quarterly results
Docs: "ViewRay Reports Second Quarter 2016 Financial Results"
05/13/2016 8-K Form 8-K - Current report
03/28/2016 8-K Form 8-K - Current report
11/09/2015 8-K Quarterly results
Docs: "ViewRay Reports Third Quarter 2015 Financial Results Company Sees Growing Momentum in Orders and Installations"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy